{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:46:20Z","timestamp":1792115180777,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Reversible splenial lesion syndrome (RESLES) was reported to be associated with variable entities. However, much less is known about the cases in which the mental disorders act as the only manifestation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Total ten patients of RESLES were obtained in this retrospective study from Shenzhen Kangning Hospital. T1-fluid attenuated inversion recovery (T1-FLAIR), T2-weighted images, T2-FLAIR, diffusion-weighted images and apparent diffusion coefficient map were performed on all the patients. Clinical manifestations, laboratory examination results, magnetic resonance imaging (MRI) findings, treatments and outcomes were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>All patients showed different mental disorders as the only manifestation. There were two cases of alcohol abuse, one of Asperger\u2019s syndrome with malnutrition, one of infection and one of invasive pituitary adenoma. The other cases were diagnosis as major depressive disorder, dissociative and conversion disorders, undifferentiated somatoform disorder, unspecified psychosis and bipolar disorder, respectively. Three patients were completely recovered while the clinical symptoms of rest seven patients partially recovered at the follow-up three months later. Oval-shaped lesion centered on the splenial of corpus callosum (SCC) was observed in all patients using MRI. The lesions of SCC of all patients were completely resolved within five weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We found that RESLES might only showed mental symptoms. On the one hand, for the patients with acute mental disorders, clinicians should be alert to the possibility of RESLES caused by physical disease. On the other hand, we suggest that mental disorder might be a precipitating factor of RESLES.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12883-021-02391-6","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T05:03:01Z","timestamp":1631682181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reversible splenial lesion syndrome with mental disorders as only manifestation"],"prefix":"10.1186","volume":"21","author":[{"given":"Ziyun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangqiang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"issue":"10","key":"2391_CR1","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1111\/j.1528-1167.2005.00256.x","volume":"46","author":"O Prilipko","year":"2005","unstructured":"Prilipko O, Delavelle J, Lazeyras F, Seeck M. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review. Epilepsia. 2005;46(10):1633\u20136.","journal-title":"Epilepsia."},{"issue":"4","key":"2391_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1136\/jnnp.70.4.459","volume":"70","author":"T Polster","year":"2001","unstructured":"Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. Journal of neurology, neurosurgery, and psychiatry. 2001;70(4):459\u201363.","journal-title":"Journal of neurology, neurosurgery, and psychiatry."},{"issue":"8","key":"2391_CR3","doi-asserted-by":"publisher","first-page":"e19-20","DOI":"10.1111\/j.1468-1331.2007.01872.x","volume":"14","author":"D Renard","year":"2007","unstructured":"Renard D, Bonafe A, Heroum C. Transient lesion in the splenium of the corpus callosum after oral corticoid therapy. European journal of neurology. 2007;14(8):e19-20.","journal-title":"European journal of neurology."},{"issue":"7","key":"2391_CR4","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1212\/01.wnl.0000179301.96652.27","volume":"65","author":"S G\u00fcrtler","year":"2005","unstructured":"G\u00fcrtler S, Ebner A, Tuxhorn I, Ollech I, Pohlmann-Eden B, Woermann FG. Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal. Neurology. 2005;65(7):1032\u20136.","journal-title":"Neurology."},{"issue":"10","key":"2391_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.braindev.2016.04.011","volume":"38","author":"WX Chen","year":"2016","unstructured":"Chen WX, Liu HS, Yang SD, et al. Reversible splenial lesion syndrome in children: Retrospective study and summary of case series. Brain & development. 2016;38(10):915\u201327.","journal-title":"Brain & development."},{"issue":"3","key":"2391_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/1941874413476044","volume":"3","author":"AM Malik","year":"2013","unstructured":"Malik AM. The reversible corpus callosum splenium lesion associated with hypoglycemic encephalopathy. The Neurohospitalist. 2013;3(3):169.","journal-title":"The Neurohospitalist."},{"issue":"1","key":"2391_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12880-019-0323-7","volume":"19","author":"Q Yang","year":"2019","unstructured":"Yang Q, Chang CC, Liu M, Yu YQ. Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome. BMC medical imaging. 2019;19(1):35.","journal-title":"BMC medical imaging."},{"issue":"2","key":"2391_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/jnnp-2013-305979","volume":"85","author":"M Hillbom","year":"2014","unstructured":"Hillbom M, Saloheimo P, Fujioka S, Wszolek ZK, Juvela S, Leone MA. Diagnosis and management of Marchiafava-Bignami disease: a review of CT\/MRI confirmed cases. Journal of neurology, neurosurgery, and psychiatry. 2014;85(2):168\u201373.","journal-title":"Journal of neurology, neurosurgery, and psychiatry."},{"issue":"1","key":"2391_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1552-6569.2009.00427.x","volume":"20","author":"JC Garcia-Monco","year":"2010","unstructured":"Garcia-Monco JC, Mart\u00ednez A, Brochado AP, Saralegui I, Cabrera A, Beldarrain MG. Isolated and reversible lesions of the corpus callosum: a distinct entity. J Neuroimaging. 2010;20(1):1\u20132.","journal-title":"J Neuroimaging"},{"issue":"2","key":"2391_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/1941874413496793","volume":"4","author":"M Oquist","year":"2014","unstructured":"Oquist M, Farooq MU, Gorelick PB. Restricted diffusion of the splenium of the corpus callosum in viral meningitis. The Neurohospitalist. 2014;4(2):109\u201310.","journal-title":"The Neurohospitalist."},{"issue":"4","key":"2391_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jiph.2016.08.019","volume":"10","author":"G Avcu","year":"2017","unstructured":"Avcu G, Kilinc MA, Eraslan C, Karapinar B, Vardar F. Mild encephalitis\/encephalopathy with reversible splenial lesion (MERS) associated with Streptococcus pneumoniae Bacteraemia. Journal of infection and public health. 2017;10(4):479\u201382.","journal-title":"Journal of infection and public health."},{"issue":"4","key":"2391_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0150-9861(06)77268-6","volume":"33","author":"M Maeda","year":"2006","unstructured":"Maeda M, Tsukahara H, Terada H, et al. Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions. Journal of neuroradiology = Journal de neuroradiologie. 2006;33(4):229\u201336.","journal-title":"Journal of neuroradiology = Journal de neuroradiologie."},{"issue":"6","key":"2391_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.yebeh.2003.08.029","volume":"4","author":"O Devinsky","year":"2003","unstructured":"Devinsky O, Laff R. Callosal lesions and behavior: history and modern concepts. Epilepsy & behavior: E&B. 2003;4(6):607\u201317.","journal-title":"Epilepsy & behavior: E&B."},{"issue":"2","key":"2391_CR14","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1148\/rg.2017160085","volume":"37","author":"J Starkey","year":"2017","unstructured":"Starkey J, Kobayashi N, Numaguchi Y, Moritani T. Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and Manifestations. Radiographics: a review publication of the Radiological Society of North America, Inc. 2017;37(2):562\u201376.","journal-title":"Radiographics: a review publication of the Radiological Society of North America, Inc."},{"key":"2391_CR15","doi-asserted-by":"publisher","first-page":"116941","DOI":"10.1016\/j.jns.2020.116941","volume":"415","author":"M Hayashi","year":"2020","unstructured":"Hayashi M, Sahashi Y, Baba Y, Okura H, Shimohata T. COVID-19-associated mild encephalitis\/encephalopathy with a reversible splenial lesion. Journal of the neurological sciences. 2020;415:116941.","journal-title":"Journal of the neurological sciences."},{"issue":"2","key":"2391_CR16","doi-asserted-by":"publisher","first-page":"e1-14","DOI":"10.1111\/j.1552-6569.2008.00279.x","volume":"21","author":"JC Garcia-Monco","year":"2011","unstructured":"Garcia-Monco JC, Cortina IE, Ferreira E, et al. Reversible splenial lesion syndrome (RESLES): what\u2019s in a name? J Neuroimaging. 2011;21(2):e1-14.","journal-title":"J Neuroimaging"},{"issue":"1","key":"2391_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1046\/j.1471-4159.2003.01984.x","volume":"87","author":"B Hassel","year":"2003","unstructured":"Hassel B, Boldingh KA, Narvesen C, Iversen EG, Skrede KK. Glutamate transport, glutamine synthetase and phosphate-activated glutaminase in rat CNS white matter. A quantitative study. Journal of neurochemistry. 2003;87(1):230\u20137.","journal-title":"Journal of neurochemistry."},{"issue":"2","key":"2391_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0169-328X(99)00072-8","volume":"67","author":"M Domercq","year":"1999","unstructured":"Domercq M, Matute C. Expression of glutamate transporters in the adult bovine corpus callosum. Brain research Molecular brain research. 1999;67(2):296\u2013302.","journal-title":"Brain research Molecular brain research."},{"issue":"6","key":"2391_CR19","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/j.1471-4159.2009.05889.x","volume":"108","author":"S Goursaud","year":"2009","unstructured":"Goursaud S, Kozlova EN, Maloteaux JM, Hermans E. Cultured astrocytes derived from corpus callosum or cortical grey matter show distinct glutamate handling properties. Journal of neurochemistry. 2009;108(6):1442\u201352.","journal-title":"Journal of neurochemistry."},{"issue":"2","key":"2391_CR20","first-page":"216","volume":"26","author":"T Moritani","year":"2005","unstructured":"Moritani T, Smoker WR, Sato Y, Numaguchi Y, Westesson PL. Diffusion-weighted imaging of acute excitotoxic brain injury. AJNR American journal of neuroradiology. 2005;26(2):216\u201328.","journal-title":"AJNR American journal of neuroradiology."},{"issue":"3","key":"2391_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0303-8467(00)00079-2","volume":"102","author":"H Takayama","year":"2000","unstructured":"Takayama H, Kobayashi M, Sugishita M, Mihara B. Diffusion-weighted imaging demonstrates transient cytotoxic edema involving the corpus callosum in a patient with diffuse brain injury. Clinical neurology and neurosurgery. 2000;102(3):135\u20139.","journal-title":"Clinical neurology and neurosurgery."},{"issue":"4","key":"2391_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/NRL.0b013e31821a25ae","volume":"17","author":"SH Lee","year":"2011","unstructured":"Lee SH, Kim SS, Kim SH, Lee SY. Acute Marchiafava-Bignami disease with selective involvement of the precentral cortex and splenium: a serial magnetic resonance imaging study. The neurologist. 2011;17(4):213\u20137.","journal-title":"The neurologist."},{"issue":"1","key":"2391_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.expneurol.2006.09.025","volume":"204","author":"S Takefuji","year":"2007","unstructured":"Takefuji S, Murase T, Sugimura Y, et al. Role of microglia in the pathogenesis of osmotic-induced demyelination. Experimental neurology. 2007;204(1):88\u201394.","journal-title":"Experimental neurology."},{"issue":"6","key":"2391_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1034\/j.1600-0404.2002.01253.x","volume":"106","author":"KK Tha","year":"2002","unstructured":"Tha KK, Terae S, Sugiura M, et al. Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy. Acta neurologica Scandinavica. 2002;106(6):379\u201386.","journal-title":"Acta neurologica Scandinavica."},{"key":"2391_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12879-016-1556-5","volume":"16","author":"ZF Yuan","year":"2016","unstructured":"Yuan ZF, Shen J, Mao SS, et al. Clinically mild encephalitis\/encephalopathy with a reversible splenial lesion associated with Mycoplasma pneumoniae infection. BMC infectious diseases. 2016;16:230.","journal-title":"BMC infectious diseases."},{"issue":"4","key":"2391_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neurad.2009.12.005","volume":"37","author":"P Hantson","year":"2010","unstructured":"Hantson P, Hernalsteen D, Cosnard G. Reversible splenial lesion syndrome in cerebral malaria. Journal of neuroradiology = Journal de neuroradiologie. 2010;37(4):243\u20136.","journal-title":"Journal of neuroradiology = Journal de neuroradiologie."},{"issue":"3","key":"2391_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/jdi.12597","volume":"8","author":"K Kaino","year":"2017","unstructured":"Kaino K, Kumagai R, Furukawa S, et al. Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine. Journal of diabetes investigation. 2017;8(3):392\u20134.","journal-title":"Journal of diabetes investigation."},{"issue":"1","key":"2391_CR28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0972-2327.145287","volume":"18","author":"SC Udaya","year":"2015","unstructured":"Udaya SC, Chauhan BN, Philip VJ. Bright splenium of a psychotic mind. Annals of Indian Academy of Neurology. 2015;18(1):80\u20133.","journal-title":"Annals of Indian Academy of Neurology."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02391-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02391-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02391-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T11:01:32Z","timestamp":1725793292000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02391-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2391"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02391-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"1 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and was approved by the ethics committee of Shenzhen Kangning Hospital (2020-K010-01), and informed consent was written by the patients or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}